Pathogenesis of varicose veins

European Journal of Vascular and Endovascular Surgery

Volumn 25, Issue 4, 2003, Pages 319-324

  Golledge, J ^a   Quigley, F G ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

Pathogenesis; Varicose veins

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; PROSTACYCLIN; PROSTAGLANDIN E2; THROMBOXANE A2; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ECHOGRAPHY; ENDOTHELIUM LESION; HUMAN; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VARICOSIS; VASCULAR ENDOTHELIUM; VEIN DILATATION; VEIN INSUFFICIENCY; VEIN VALVE; VEIN WALL;

EID: 0038743336     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.2002.1843     Document Type: Article

References (57)

1. BRADBURY A, EVANS C, ALLAN P, LEE A, RUCKLEY CV, FOWKES FGR. What are the symptoms of varicose veins? Edinburgh vein study cross sectional population survey. BMJ 1999; 318: 353-356.
2. CALLAM MJ. Epidemiology of varicose veins. Br J Surg 1994; 81: 167-173.
3. LONDON NJM, NASH R. Varicose veins. BMJ 2000; 320: 1391-1394.
4. CALLAM MJ, RUCKLEY CV, HARPER DR, DALE JJ. Chronic ulceration of the leg: extent of the problem and provision of care. Br Med J Clin Res Ed 1985; 290: 1855-1856.
5. RUCKLEY CV, CALLAM MJ, DALE JJ. Causes of chronic leg ulceration. Lancet 1982; 2: 615-616.
6. COLERIDGE SMITH PD. Update on chronic-venous-insufficiency-induced inflammatory processes. Angiology 2001; 52(Suppl. 1): S35-S42.
7. LABROPOULOS N, DELIS K, NICOLAIDES AN, LEON M, RAMASWAMI G, VOLTEAS N. The role of the distribution and anatomic extent of reflux in the development of signs and symptoms in chronic venous insufficiency. J Vasc Surg 1996; 23: 504-510.
8. EVANS CJ, FOWKES FG, RUCKLEY CV, LEE AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study J Epidemiol Comm Health 1999; 53: 149-153.
9. TUCHSEN F, KRAUSE N, HANNERZ H, BURR H, KRISTENSEN TS. Standing at work and varicose veins. Scand J Work Environ Health 2000; 26: 414-420.
10. BEAGLEHOLE R. Epidemiology of varicose veins. W J Surg 1986; 10: 898-902.
11. BURKITT DP. Varicose veins, deep vein thrombosis and haemorrhoids: Epidemiology and suggested aetiology. BMJ 1972; 2: 556-561.
12. FOWKES FG, LEE AJ, EVANS CJ, ALLAN PL, BRADBURY AW, RUCKLEY CV. Lifestyle risk factors for lower limb venous reflux in the general population: Edinburgh Vein Study. Int J Epidemiol 2001; 30: 846-852.
13. LABROPOULOS N, GIANNOUKAS AD, DELIS K et al. Where does venous reflux start? J Vasc Surg 1997; 26: 736-742.
14. LABROPOULOS N, TASSIOPOULOS AK, KANG SS, MANSOUR MA, LITTOOY FN, BAKER WH. Prevalence of deep venous reflux in patients with primary superficial vein incompetence. J Vasc Surg 2000; 32: 663-668.
15. STUART WP, ADAM DJ, ALLAN PL, RUCKLEY CV, BRADBURY AW. Saphenous surgery does not correct perforator incompetence in the presence of deep venous reflux. J Vasc Surg 1998; 28: 834-838.
16. MEISSNER MH, CAPS MT, ZIERLER BK, BERGELIN RO, MANZO RA, STRANDNESS DE. Deep venous thrombosis and superficial venous reflux. J Vasc Surg 2000; 32: 48-56.
17. HAENEN JH, WOLLERSHEIM H, JANSSEN MC et al. Evolution of deep venous thrombosis: a 2-year follow-up using duplex ultrasound scan and strain-gauge plethysmography. J Vasc Surg 2001; 34: 649-655.
18. O'SHAUGHNESSY AM, FITZGERALD, DE. The patterns and distribution of residual abnormalities between the individual proximal venous segments after an acute deep vein thrombosis. J Vasc Sury 2001; 33: 379-384.
19. LOPEZ-BERET P, ORCAZ A, FONTCUBERTA J et al. Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis. J Vasc Surg 2001; 33: 77-90.
20. MEISSNER MH, CAPS MT, ZIERLER BK et al. Determinants of chronic venous disease after acute deep venous thrombosis. J Vasc Surg 1998; 28: 826-833.
21. MASUDA EM, KESSLER DM, KISTNER RL, EKLOF B, SATO DT. The natural history of calf vein thrombosis: Lysis of thrombi and development of reflux. J Vasc Surg 1998; 28: 67-74.
22. HAENEN JH, JANSSEN MCH, VAN LANGEN H et al. Duplex ultrasound in the hemodynamic evaluation of the late sequelae of deep venous thrombosis. J Vasc Surg 1998; 27: 472-478.
23. VAN RAMSHORST B, VAN BEMMELEN PS, HOENEVELD H, EIKELBOOM BC. The development of valvular incompetence after deep vein thrombosis: a follow-up study with duplex scanning. J Vasc Surg 1994; 19: 1059-1066.
24. SCURR JH, MACHIN SJ, BAILEY-KING S, MACKIE IJ, MCDONALD S, SMITH PD. Frequency and prevention of symptomless deep-vein thrombosis in long-haul flights: a randomised trial. Lancet 2001; 357: 1485-1489.
25. SCULTETUS AH, VILLAVICENCIO JL, RICH NM. Facts and fiction surrounding the discovery of the venous valves. J Vasc Surg 2001; 33(2): 435-441.
26. MOORE HD. Deep venous valves in the etiology of varicose veins. Lancet 1951; 2: 7-10.
27. ONO T, BERGAN JJ, SCHMID-SCHONBEIN GW, TAKASE S. Monocyte infiltration into venous valves. J Vasc Surg 1998; 27: 158-166.
28. LE FLEM L, MENNEN L, AUBRY ML et al. Thrombomodulin promoter mutations, venous thrombosis and varicose veins. Arterioscler Thromb Vasc Biol 2001; 21: 445-451.
29. CORCOS L, DE ANNA D, DINI M, MACCHI C, FERRARI PA, DINI S. Proximal long saphenous vein valves in primary venous insufficiency. J Mal Vasc 2000; 25: 27-36.
30. YAMAKI T, SASAKI K, NOZAKI M. Preoperative duplex-derived parameters and angioscopic evidence of valvular incompetence associated with superficial venous insufficiency. J Endovasc Ther 2002; 9: 229-233.
31. ANDREOTTI L CAMMELLI D. Connective tissue in varicose veins. Angiology 1979; 30: 798-805.
32. ANDREOTTI L, CAMMELLI D, SAMPOGNARO S et al. Biochemical analysis of dermal connective tissue in subjects affected by primary uncomplicated varicose veins. Angiology 1985; 36: 265-270.
33. GANDHI RH, IRIZARRY E, NACKMAN GB, HALPERN VJ, MULCARE RJ, TILSON MD. Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins. J Vasc Surg 1993; 18: 814-820.
34. SANSILVESTRI-MOREL P, RUPIN A, BADIER-COMMANDER C et al. Imbalance in the synthesis of collagen type I and collagen type III in smooth muscle cells derived from human varicose veins. J Vasc Res 2001; 38: 560-568.
35. BADIER-COMMANDER C, VERBEUREN T, LEBARD C, MICHEL JB, JACOB MP. Increased TIMP/MMP ratio in varicose veins: Possible explanation for extracellular matrix accumulation. J Pathol 2000; 192: 105-112.
36. GOLLEDGE J, GREENHALGH RM, DAVIES AH. The symptomatic carotid plaque. Stroke 2000; 31: 774-781.
37. CLARKE GH, VASDEKIS SN, HOBBS JT, NICOLAIDES AN. Venous wall function in the pathogenesis of varicose veins. Surgery 1992; 111: 402-408.
38. BRUNNER F, HOFFMAN C, SCHULLER-PETROVIC S. Responsiveness of human varicose saphenous vein to vasoactive agents. Br J Clin Pharmacol 2001; 51: 219-224.
39. HOLLINGSWORTH SJ, TANG CB, BAKER SGE. The effects of heparin on cultured explants of varicose long saphenous vein. Phlebology 2001; 16: 60-67.
40. AGU O, HAMILTON G, BAKER DM, DASHWOOD MR. Endothelin receptors in the aetiology and pathophysiology of varicose veins. Eur J Vasc Endovasc Surg 2002; 23: 165-171.
41. HOLLINGSWORTH SJ, TANG CB, DIALYNAS M, BARKER SG. Varicose veins: loss of release of vascular endothelial growth factor and reduced plasma nitric oxide. Eur J Vasc Endovasc Surg 2001; 22: 551-556.
42. BOIVIN P, CORNU-THENARD A, CHARPAK Y. Pregnancy-induced changes in lower extremity superficial veins: An ultrasound scan study. J Vasc Surg 2000; 32: 570-574.
43. CORDTS PR, GAWLEY TS. Anatomic and physiologic changes in lower extremity venous hemodynamics associated with pregnancy. J Vasc Surg 1996; 24: 763-767.
44. STANSBY G. Women, pregnancy and varicose veins. Lancet 2000; 355: 1117-1118.
45. PERROT-APPLANAT M, COHEN-SOLAL K, MILIGROM E, FINET M. Progesterone receptor expression in human saphenous vein. Circulation 1995; 92: 2975-2983.
46. MICHIELS C, ARNOULD T, RAMACEL J. Hypoxia-induced activation of endothelial cells as a possible cause of venous disease: hypothesis. Angiology 1993; 144: 639-646.
47. TAKASE S, BERGAN JJ, SCHMID-SCHONBEIN G. Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency. Ann Vasc Surg 2000; 14: 427-435.
48. BIAGI G, LAPILLI A, ZENDRON R, PICCINNI L, COCCHERI S. Prostanoid production in varicose veins: evidence for decreased prostacyclin with increased thromboxane A2 and prostaglandin E2 formation. Angiology 1988; 39: 1036-1042.
49. NEMCOVA S, GLOVICZKI F, RUD KS, MILLER VM. Cyclic nucleotides and production of prostanoids in human varicose veins. J Vasc Surg 1999; 30: 876-884.
50. BADIER-COMMANDER C, COUVELARD A, HENIN D, VERBEUREN T, MICHEL JB, JACOB MP. Smooth muscle cell modulation and cytokine overproduction in varicose veins. An in situ study. J Pathol 2001; 193: 398-407.
51. SHEBUSKI RJ, KILGORE KS. Role of inflammatory mediators in thrombogenesis. J Pharmacol Exp Ther 2002; 300: 729-735.
52. SMITH A, QUARMBY JW, COLLINS M, LOCKHART SM, BURNAND KG. Changes in the levels of soluble adhesion molecules and coagulation factors in patients with deep vein thrombosis. Thromb Haemost 1999; 82: 1593-1599.
53. SAHARAY M, SHIELDS DA, GEORGIANNOS SN, PORTER JB, SCURR JH, COLERIDGE SMITH PD. Endothelial activation in patients with chronic venous disease. Eur J Vasc Endovasc Surg 1998; 15: 342-349.
54. PIULACHS P, VIDAL-BARRAQUER F. Pathogenic study of varicose veins. Angiology 1953; 4: 59-100.
55. GUIS JA. Arteriovenous anastomoses and varicose veins. Observations with the operation microscope. Arch Surg 1960; 81: 299-310.
56. BARON HC, CASSARO S. The role of arteriovenous shunts in the pathogenesis of varicose veins. J Vasc Surg 1986; 4: 124-128.
57. SCOTT HJ, CHEATLE TR, MCMULLIN GM, COLERIDGE SMITH PD, SCURR JH. Reappraisal of the oxygenation of blood in varicose veins. Br J Surg 1990; 77: 934-936.